Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	127.68	45.82	7.27	8.19	20.3	16.74
Short-Term Investments	16	14.4	-	4.93	-	-
Cash & Short-Term Investments	143.68	60.21	7.27	13.12	20.3	16.74
Cash Growth	2286.61%	728.67%	-44.62%	-35.38%	21.31%	26.66%
Other Current Assets	0.41	0.08	0.07	0.05	0.22	0.06
Total Current Assets	144.09	60.29	7.33	13.17	20.52	16.8
Property, Plant & Equipment	0.11	-	0.01	0.06	-	-
Other Long-Term Assets	-	-	-	-	-	0.07
Total Assets	144.2	60.29	7.35	13.23	20.52	16.87
Accounts Payable	2.54	2.25	1.76	3.13	1.58	1.18
Accrued Expenses	-	3	-	-	-	-
Total Current Liabilities	2.57	5.25	1.76	3.13	1.58	1.18
Long-Term Leases	0.07	-	-	0.01	-	-
Total Liabilities	2.64	5.25	1.76	3.14	1.58	1.18
Common Stock	0.01	0.01	0	0.01	0.01	0.01
Additional Paid-In Capital	225.85	130.79	65.81	61.87	60.22	47.87
Retained Earnings	-84.31	-75.79	-60.21	-51.8	-41.29	-32.19
Comprehensive Income & Other	0.01	0.04	-0.01	0.01	-0	-0.01
Total Common Equity	141.56	55.04	5.59	10.09	18.94	15.69
Shareholders' Equity	141.56	55.04	5.59	10.09	18.94	15.69
Total Liabilities & Equity	144.2	60.29	7.35	13.23	20.52	16.87
Total Debt	0.1	-	-	0.01	-	-
Net Cash (Debt)	143.57	60.21	7.27	13.11	20.3	16.74
Net Cash Growth	2284.91%	728.67%	-44.58%	-35.42%	21.31%	26.66%
Net Cash Per Share	22.08	15.89	2.63	5.15	8.14	7.64
Filing Date Shares Outstanding	6.68	6.11	3.49	2.64	2.52	2.51
Total Common Shares Outstanding	6.66	6.1	2.98	2.59	2.52	2.29
Working Capital	141.52	55.04	5.58	10.04	18.94	15.62
Book Value Per Share	21.25	9.02	1.87	3.90	7.52	6.85
Tangible Book Value	141.56	55.04	5.59	10.09	18.94	15.69
Tangible Book Value Per Share	21.25	9.02	1.87	3.90	7.52	6.85

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q